Gilead Sciences (GILD) 'Crushed' the Quarter, Piper Jaffray Says; Remains Top Large-Cap Biotech Pick

Go back to Gilead Sciences (GILD) 'Crushed' the Quarter, Piper Jaffray Says; Remains Top Large-Cap Biotech Pick
Gilead Sciences (NASDAQ: GILD) Delayed: 149.37 -1.19 (0.79%)
Previous Close $150.56    52 Week High $108.63 
Open $150.65    52 Week Low $71.39 
Day High $151.20    P/E 82.52 
Day Low $148.65    EPS $1.81 
Volume 341,156